NICE has just announced that the proposal for all those with a 10% risk of developing heart disease should be offered statins has been confirmed. Effectively this means virtually everyone because even with the healthiest, fittest person there must be at least a 10% chance heart disease will cause their death. Perhaps “the great and […]
GlaxoSmithKline (GSK) was recently accused of offering substantial sums as bribes in order to facilitate sales of their products in China. This is not the first time the drug company has encountered problems because of behaviour which fails to match up to the highest standards of corporate social responsibility. In 2007 Steven Nissen and Kathy
If drugs are to be effective and safe to use, it is axiomatic that the regulatory process has the power, resources and competence to be capable of validating all the information which has to assessed before official approval can be granted. Genuine doubts have frequently been expressed which indicate that the regulation of drugs is
Now that the Pfizer attempt to take over Astra Zeneca has failed it is relevant to take a detailed look at the drug companies. In particular we need to know what exactly they achieve in terms of improving standards of public health and the costs involved. In fact it is not necessary to dig very
84. Time to put the Drug Companies under the Microscope Read More »